Featured
India’s Got Latent Season 2 May Stream on Netflix, Fans Worry About Possible Censorship
Dr. Jyotsna Singh: Advancing Neuroscience, Healthcare Innovation, and Women-Led Scientific Leadership-TBT
Dr. Jyotsna Singh Isn’t Just Studying the Brain—She’s Reimagining Healthcare
Surat goods train railway line controversy, the blunt times
Surat : Farmers Stop Mysterious Railway Survey at Vinjolia Amid Confusion and Tension
June 17, 2026
The Blunt Times The Blunt Times
  • National
  • City Events
  • Business Vibes
  • Education
  • Entertainment
  • Regional
    • Bharuch
    • Dang
    • Navsari
    • Surat
    • Valsad
    • Hindi
    • Gujarati
  • Health
  • Crime corner
  • Sports
  • Spotlight
Search the Site
Popular Searches:
Chatgpt Nasa Halloween
Recent Posts
5 Must-Try Affordable Long-Lasting Luxury Perfumes for Men-TBT
5 Must-Try Affordable Long-Lasting Luxury Perfumes for Men
June 17, 2026
Ahmedabad Spine Institute Medicity, the blunt times
Rs.295 Crore Spine Institute to Transform Ahmedabad Medicity into Global Sports Medicine Hub
June 17, 2026
Geon Completes Battery Energy Storage System Integration of 2.88 GWh Project in Khavda, Gujarat-TBT
Geon Completes Battery Energy Storage System Integration of 2.88 GWh Project in Khavda, Gujarat
June 17, 2026
The Blunt Times The Blunt Times
  • National
  • City Events
  • Business Vibes
  • Education
  • Entertainment
  • Regional
    • Bharuch
    • Dang
    • Navsari
    • Surat
    • Valsad
    • Hindi
    • Gujarati
  • Health
  • Crime corner
  • Sports
  • Spotlight
Follow us
Home/Business Vibes/JLF Life Sciences IPO intends to raise Rs 1816 lakh through 29.78 lakh equity shares
Business Vibes

JLF Life Sciences IPO intends to raise Rs 1816 lakh through 29.78 lakh equity shares

[ad_1] New Delhi [India] : JFL Life Sciences Limited, engaged in the business of manufacturing pharmaceutical products having experience of more than a decade, is all set to raise Rs 1,816.58 Lakhs...

Times News Network
August 26, 2022 2 Min Read

[ad_1]

New Delhi [India] : JFL Life Sciences Limited, engaged in the business of manufacturing pharmaceutical products having experience of more than a decade, is all set to raise Rs 1,816.58 Lakhs through an initial public offering (IPO). The issue opened on the 25th of August and listed on NSE Emerge.

The public issue of JFL Life Sciences Limited is of 29,78,000 equity shares of Face Value ₹10 each (“EQUITY SHARES”) for cash at a price of ₹ 61/- per equity share (including a securities premium of ₹ 51/- per equity share) (the issue price) aggregating ₹ 1,816.58 LACS of the issue. 1,50,000 equity shares aggregating to ₹ 91.50 Lakhs will be reserved for market maker (“Market Maker Reservation Portion”). The issue, less the Market Maker Reservation Portion, i.e., issue of 28,28,000 equity shares of Face Value of ₹ 10/- EACH at an issue price of ₹ 61/- per equity share, aggregating to ₹ 1,725.08 Lakhs, which is hereinafter referred to as “The Net Issue”. The issue and the Net Issue will constitute 27.08% AND 25.71%, respectively of the post issue paid up equity share capital of the company. The company will list at NSE Emerge. The Lead manager of the issue is GYR Capital Advisors Pvt Ltd and the Registrar to the issue is KFin Technologies Ltd. The issue opens on the 25th of August and will close on the 30th of August, 2022 and will subsequently be listed on NSE Emerge.

The company intends to utilize the proceeds of the Issue to meet the following objectives:

1. Repayment of secured and unsecured loans

2. Funding the working capital requirements of the company

3. General Corporate Purposes

 

 

JFL Life Sciences Limited is engaged in the business of manufacturing pharmaceutical products. Their product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS). With market presence in pan India, products of JFL supplies to 10 developed and developing countries throughout the World. To maintain its competitiveness and to further the cause of health care JFL has laid a strong R&D foundation and an FDA approved state of the art manufacturing facility near Ahmedabad.

 

The Company has registered their products to manufacture in various countries like sovereign of Kenya, Nigeria, Yemen & Myanmar. Few of their products are also registered with Ukraine, Uzbekistan, and Kazakhstan as well. This also makes them a ‘one-stop-shop’ service provider for catering to all of the customer’s needs domestically as well as internationally.

The promoters, Mr. Smiral Ashwinbhai Patel and Tejal Smiralbhai Patel are actively involved in the day-to-day business of the company and are the guiding force behind the strategic decisions for the Company. Their management team and other key management personnel are well qualified and have extensive industry expertise, and have been responsible for the operational growth.



[ad_2]

Share Article

Previous Post

Lorein Finance clocks USD 75 million in student loan applications within weeks of its launch

Next Post

EZOK brand for men’s footwear launched with 150 SKUs

Picked
AM/NS -PNn
AM/NS India Introduces Zagnelis® Protect, a World-Class Patented Steel for the Automotive Industry
India’s Got Latent Season 2 May Stream on Netflix, Fans Worry About Possible Censorship
Dr. Jyotsna Singh: Advancing Neuroscience, Healthcare Innovation, and Women-Led Scientific Leadership-TBT
Dr. Jyotsna Singh Isn’t Just Studying the Brain—She’s Reimagining Healthcare
Surat goods train railway line controversy, the blunt times
Surat : Farmers Stop Mysterious Railway Survey at Vinjolia Amid Confusion and Tension
SSG Hospital namaz video, the blunt times
Viral Namaz Video at Vadodara’s SSG Hospital Sparks Inquiry
MYCPE ONE Mexico expansion, the blunt times
MYCPE ONE Enters Mexico, Eyes Latin America Growth
Popular Posts
SSG Hospital namaz video, the blunt times
Viral Namaz Video at Vadodara’s SSG Hospital Sparks Inquiry
By Times News Network
MYCPE ONE Mexico expansion, the blunt times
MYCPE ONE Enters Mexico, Eyes Latin America Growth
By Times News Network
IITM Pravartak Announces Batch 03 of Applied Artificial Intelligence and Deep Learning Programme to Build Enterprise-Ready AI Talent-TBT
IITM Pravartak Announces Batch 03 of Applied Artificial Intelligence and Deep Learning Programme to Build Enterprise-Ready AI Talent
By TBT Online Desk
Dr. Pankaj Gandhi, director of MANTRA on PM MITRA Park Navsari, the blunt times
PM MITRA Park, Navsari : South Gujarat Cannot Afford To Lose This Historic Opportunity
By Times News Network
Surat Nasirnagar demolition victims toilet crisis, the blunt times
Surat : 18 Days After Demolition, Nasirnagar Demolition Victims Still Without Toilets
By Times News Network
Gujarat bomb threat emails, the blunt times
Bomb Threat Emails Trigger Massive Security Alert Across Gujarat
By Times News Network

Read Next

JLite becomes Jainam App, the blunt times
Business Vibes
Jainam Rebrands JLite as Jainam App in Major Digital Identity Shift
June 15, 2026
2 Min Read
Mercury EV Tech NSE listing, the blunt times
Business Vibes
Gujarat : Mercury EV Tech makes strong NSE debut
June 2, 2026
2 Min Read
Ice Make FY26 results, the blunt times
Business Vibes
Gujarat : Ice Make Posts Record Rs.256 Cr Q4 Revenue, FY26 Up 39 Pc
June 1, 2026
1 Min Read
India jewellery innovation challenge, the blunt times
Business Vibes
GJEPC launches India’s first jewellery innovation challenge
May 29, 2026
4 Min Read
The Blunt Times

The Blunt Times is a 24-hour news portal from Surat and south Gujarat. It was launched by senior journalist Melvyn Thomas, who has over 21 years of experience working with the top news organizations such as The Indian Express, The Times of India, and The Economic Times.

Popular
AM/NS India Introduces Zagnelis® Protect, a World-Class Patented Steel for the Automotive Industry
June 17, 2026
India’s Got Latent Season 2 May Stream on Netflix, Fans Worry About Possible Censorship
June 17, 2026
Dr. Jyotsna Singh Isn’t Just Studying the Brain—She’s Reimagining Healthcare
June 17, 2026
Surat : Farmers Stop Mysterious Railway Survey at Vinjolia Amid Confusion and Tension
June 17, 2026
Categories
City Events
National
Business Vibes
Lifestyle
Spotlight
Regional
Education
Entertainment
Health
Press Release
Business
Sports

© 2026 All Rights Reserved, The Blunt Times

  • Terms of Service
  • Privacy Policy